REPLIGEN CORP (RGEN) Stock Analyst Ratings
USA - NASDAQ:RGEN - US7599161095 - Common Stock
149.06 USD
+4.49 (+3.11%)
149.06 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to RGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 181.69. This target is 21.89% above the current price.
RGEN was analyzed by 27 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RGEN.
In the previous month the buy percentage consensus was at a similar level.
RGEN was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-29 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-29 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-01 | HSBC | Initiate | Buy |
| 2025-09-22 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2025-09-12 | Jefferies | Maintains | Hold -> Hold |
| 2025-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-30 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-08 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-06-24 | Barclays | Initiate | Overweight |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-17 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-04-16 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-03-18 | Evercore ISI Group | Initiate | In-Line |
| 2025-02-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-21 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-17 | Canaccord Genuity | Initiate | Hold |
| 2024-11-14 | Wolfe Research | Initiate | Peer Perform |
| 2024-09-26 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-27 | Wells Fargo | Initiate | Overweight |
| 2024-08-05 | Benchmark | Reiterate | Hold |
| 2024-07-31 | UBS | Maintains | Buy -> Buy |
REPLIGEN CORP / RGEN FAQ
What do analysts expect the price target to be for REPLIGEN CORP (RGEN)?
27 analysts have analysed RGEN and the average price target is 181.69 USD. This implies a price increase of 21.89% is expected in the next year compared to the current price of 149.06.
What is the consensus rating for REPLIGEN CORP (RGEN) stock?
The consensus rating for REPLIGEN CORP (RGEN) is 80.7407 / 100 . This indicates that analysts generally have a positive outlook on the stock.